Pharmaceutical Executive
Preserving positive ROI amid healthcare’s innovation explosion.
Chrissy Bell
Advertisement
Articles by Chrissy Bell
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Trump Administration Adds Nine Drugmakers to Most-Favored-Nation Program: Report
2
Eli Lilly to Acquire Merida Biosciences for $2.8 Billion
3
Simcere Zaiming Licenses Sim0660 to Roche for $1.53 billion
4
Pharmaceutical Executive Daily: Eli Lilly Enters $2.8 Billion Agreement to Acquire Merida Biosciences
5